Intravesical Instillation of Adriamycin Early after Transurethral Resection: Measurements of Plasma Levels
- 1 January 1984
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 10 (6) , 398-400
- https://doi.org/10.1159/000463843
Abstract
Ten patients with frequently recurrent or wide-spread papillary tumors of the urinary bladder were treated by intravesical instillation of adriamycin (50-110 mg) within 3 h of transurethral resection of the tumors. The highest plasma concentration observed (73 ng/ml) was associated with the most extensive resection. In no other patient did the maximum plasma concentration exceed 30 ng/ml. Mostly, the intravesical instillation of adriamycin was given in immediate connection with the transurethral resection. Hence, the remaining effects from the epidural anesthesia eliminated all patients'' discomfort related to the instillation therapy. In no patient was the combined therapy discontinued due to side effects.This publication has 5 references indexed in Scilit:
- Influence of Thiotepa and Doxorubicin Instillation at Time of Transurethral Surgical Treatment of Bladder Cancer on Tumor Recurrence: A Prospective, Randomized, Double-Blind, Controlled TrialJournal of Urology, 1983
- Therapy-Related LeukemiaOncology, 1983
- Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinolJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Intravesical Thio-tepa in the Immediate Postoperative Period in Patients with Recurrent Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- PLASMA PHARMACOKINETICS OF ADRIAMYCIN AND ITS METABOLITES IN HUMANS WITH NORMAL HEPATIC AND RENAL-FUNCTION1977